Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd Allots 11,025,380 Bonus Equity Shares
BONUS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 17 Jul 2026, 01:05 PM IST · BSE ID: 35ce9974-cf44-4623-9444-3736daa8f48c
View Original BSE Filing (PDF)
💡
In Simple Terms
Fredun Pharmaceuticals gave shareholders two new shares for every one they owned, boosting its total share capital.
🤖 AI Summary
- Fredun Pharmaceuticals allotted 11,025,380 bonus equity shares in a 2:1 ratio.
- Existing shareholders receive two new shares for every one held as of July 16, 2026.
- Company's paid-up equity share capital increased from Rs. 5,51,26,900 to Rs. 16,53,80,700.
- Allotted bonus shares rank pari-passu with existing equity shares.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Bonus Equity Shares Allotted
11025380
Face Value per Share
₹ 10/-
Paid-up share capital (Pre-Bonus Issue)
Rs. 5,51,26,900
Paid-up share capital (Post-Bonus Issue)
Rs. 16,53,80,700
🏢 How This Affects the Company
The company's issued and paid-up equity share capital has increased significantly following the bonus share allotment. The total equity share capital grew from Rs. 5,51,26,900 to Rs. 16,53,80,700.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders for this bonus share allotment. Shares will be credited directly to their demat accounts.
👤
Who Is Affected
All equity shareholders of Fredun Pharmaceuticals Limited holding shares as of the record date, July 16, 2026, are affected. They will receive 2 bonus shares for every 1 existing share held.
🔍
Management Signal
The bonus share issuance signals management's intent to reward existing shareholders and potentially increase the company's share attractiveness.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Future financial results disclosure
Any further corporate actions announced by the company
Shareholder communication regarding allotment confirmation
LOW RISK
Bonus share allotment is a standard corporate action with no inherent new risks disclosed.
💡 Investor Takeaway
Fredun Pharmaceuticals allotted 11,025,380 bonus shares (2:1 ratio), increasing paid-up capital from Rs. 5,51,26,900 to Rs. 16,53,80,700. New shares rank pari-passu.
⚖️ Strengths & Concerns
✅ Positives
- Allotment of 11,025,380 bonus equity shares in a 2:1 ratio to reward shareholders.
- Increase in issued and paid-up equity share capital from Rs. 5,51,26,900 to Rs. 16,53,80,700.
❓ Frequently Asked Questions
How many bonus shares has Fredun Pharmaceuticals allotted?
Fredun Pharmaceuticals has allotted 11,025,380 fully paid-up bonus equity shares.
What is the bonus share ratio for Fredun Pharmaceuticals?
The bonus share ratio is 2:1, meaning 2 new bonus equity shares for every 1 existing equity share.
What was Fredun Pharmaceuticals' paid-up share capital before the bonus issue?
The paid-up share capital before the bonus issue was Rs. 5,51,26,900.
What is Fredun Pharmaceuticals' paid-up share capital after the bonus issue?
Following the bonus issue, the paid-up share capital stands at Rs. 16,53,80,700.
When was the record date for Fredun Pharmaceuticals' bonus share issue?
The record date for the bonus share issue was July 16, 2026.
Questions based on this BSE filing only. For information purposes.